In 2025, Genmab disclosed key data related to its energy management practices, providing transparency into its operational energy use in line with recognized sustainability reporting frameworks.
Genmab disclosed progress toward renewable energy adoption, highlighting the share of total energy sourced from renewable versus non-renewable sources.
| Metric (GJ) | 2025 | 2024 |
|---|---|---|
Total Energy Consumption | 45,824a | 45,731a |
Non-Renewable Energy Consumption | 16,088a | 18,763a |
Renewable Energy Consumption | 29,736a | 26,968a |
Renewable Energy Production | 421a | 277a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, Genmab consumed a total of 45,824.4 Gigajoules of energy across its operations. Of this total, 64.89% was sourced from renewable energy, either derived from natural resources like biofuels, biomass, or biogas, or generated using renewable technologies such as solar or wind power. The remaining 35.11% was classified as non-renewable energy, coming from fossil-based fuels such as coal, natural gas, or crude oil, or from non-renewable generation technologies like nuclear power.a
In 2025, Genmab consumed a total of 45,824.4 Gigajoules of energy, of which 64.89% was derived from renewable sources, including biofuels, biomass, biogas, solar, and wind power.a
This moderate level of renewable energy adoption indicates that Genmab is transitioning toward cleaner energy sources, though a significant share of its energy mix still relies on non-renewable inputs.
Since 2025, Genmab's total energy consumption has remained relatively stable, indicating no significant changes in energy use patterns.a
Over the same period, the share of renewable energy in Genmab's consumption increased by 10.04%, showing a recent positive trend in clean energy adoption.a